Valuation: Rapid Micro Biosystems, Inc.

Market Cap 104M 90.5M 84.72M 77.51M 146M 9.92B 148M 992M 389M 4.96B 391M 383M 16.52B P/E 2026 *
-2.24x
P/E 2027 * -2.63x
Enterprise Value 104M 90.5M 84.72M 77.51M 146M 9.92B 148M 992M 389M 4.96B 391M 383M 16.52B EV / Sales 2026 *
2.65x
EV / Sales 2027 * 2.24x
Free-Float
86.1%
Yield 2026 *
-
Yield 2027 * -
1 day-1.42%
1 week+1.46%
Current month-2.35%
1 month+20.93%
3 months-16.13%
6 months-43.48%
Current year-28.28%
1 week 2.02
Extreme 2.015
2.2
1 month 1.7
Extreme 1.7
2.26
Current year 1.66
Extreme 1.66
4.94
1 year 1.66
Extreme 1.66
4.94
3 years 0.58
Extreme 0.58
4.94
5 years 0.58
Extreme 0.58
24.42
10 years 0.58
Extreme 0.58
27.04
Manager TitleAgeSince
Chief Executive Officer 57 2014-09-30
Director of Finance/CFO 56 2018-09-30
Chief Tech/Sci/R&D Officer - 2025-04-30
Director TitleAgeSince
Director/Board Member 56 2018-09-30
Director/Board Member 57 2014-09-30
Director/Board Member 77 2016-03-14
Date Insider Type Main position Quantity % Market Cap.
7/24/26 Fiscal year

Director

7,016 0.0155%
7/22/26 Fiscal year

Chief Executive Officer

2,804 0.0062%
3/11/26 Sell

Chief Financial Officer

7,480 0.0188%
Change 5-day change 1-year change 3-year change Capi.($)
-1.42%+1.46%-39.18%+126.09% 104M
+0.38%+0.62%+24.36%+5.72% 214B
+0.16%+1.78%+0.47%-21.50% 140B
-0.40%+5.84%-21.65%+20.82% 133B
+3.27%+7.08%-52.97%-2.80% 69.19B
+0.39%+4.15%+12.72%+12.28% 51.28B
-0.36%+4.16%-14.57%-20.67% 50.43B
+0.16%+0.74%+23.02%+11.91% 39.85B
-0.08%+5.33%+42.15%+37.88% 39.27B
-0.35%+4.18%-21.67%+24.54% 32.32B
Average +0.20%+3.69%-4.73%+19.43% 76.9B
Weighted average by Cap. +0.40%+3.04%+0.68%+4.07%

Financials

2026 *2027 *
Net sales 39.3M 34.11M 31.93M 29.21M 55.08M 3.74B 55.9M 374M 147M 1.87B 148M 144M 6.23B 46.58M 40.42M 37.84M 34.62M 65.27M 4.43B 66.25M 443M 174M 2.22B 175M 171M 7.38B
Net income -44.7M -38.79M -36.32M -33.23M -62.64M -4.25B -63.58M -425M -167M -2.13B -168M -164M -7.08B -39.07M -33.91M -31.74M -29.04M -54.75M -3.72B -55.57M -372M -146M -1.86B -147M -143M -6.19B
Net Debt - -
Logo Rapid Micro Biosystems, Inc.
Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission-critical automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
Employees
171
Date Price Change Volume
26-08-06 US$2.080 -1.42% 69,988
26-08-05 US$2.110 +2.43% 29,819
26-08-04 US$2.060 -2.83% 198,552
26-08-03 US$2.120 -0.47% 119,040
26-07-31 US$2.130 +0.95% 20,558
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.080USD
Average target price
6.667USD
Spread / Average Target
+220.51%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RPID Stock